Cargando…

Pan-Cancer Analysis Identifies MNX1 and Associated Antisense Transcripts as Biomarkers for Cancer

The identification of diagnostic and prognostic biomarkers is a major objective in improving clinical outcomes in cancer, which has been facilitated by the availability of high-throughput gene expression data. A growing interest in non-coding genomic regions has identified dysregulation of long non-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ragusa, Denise, Tosi, Sabrina, Sisu, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688723/ https://www.ncbi.nlm.nih.gov/pubmed/36429006 http://dx.doi.org/10.3390/cells11223577

Ejemplares similares

MNX1-AS1 is a functional oncogene that induces EMT and activates the AKT/mTOR pathway and MNX1 in breast cancer
por: Cheng, Yue, et al.
Publicado: (2019)

LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis
por: Li, Fengwei, et al.
Publicado: (2020)

Pan-Cancer Analysis Reveals the Diverse Landscape of Novel Sense and Antisense Fusion Transcripts
por: Vellichirammal, Neetha Nanoth, et al.
Publicado: (2020)

Expression, Clinical Significance, and Functional Prediction of MNX1 in Breast Cancer
por: Tian, Tian, et al.
Publicado: (2018)

MNX1 Promotes Malignant Progression of Cervical Cancer via Repressing the Transcription of p21(cip1)
por: Zhu, Biqing, et al.
Publicado: (2020)

Actinidia chinensis Planch Root extract suppresses the growth and metastasis of hypopharyngeal carcinoma by inhibiting E2F Transcription Factor 1-mediated MNX1 antisense RNA 1
por: Zheng, Yi, et al.
Publicado: (2022)

MNX1 facilitates the malignant progress of lung adenocarcinoma through transcriptionally upregulating CCDC34
por: Wu, Junhua, et al.
Publicado: (2023)

PB1808: EPIGENETIC INHIBITOR SCREEN TO IDENTIFY THERAPEUTIC CANDIDATES FOR MNX1-OVEREXPRESSING AML
por: Kelekci, Simge, et al.
Publicado: (2023)

Expression and significance of LncRNA MNX1-AS1 in non-small cell lung cancer
por: Liu, Gaofeng, et al.
Publicado: (2019)

Novel MNX1 mutations and genotype–phenotype analysis of patients with Currarino syndrome
por: Han, Lu, et al.
Publicado: (2020)

Knockdown of lncRNA MNX1‐AS1 suppresses cell proliferation, migration, and invasion in prostate cancer
por: Li, Zongwu, et al.
Publicado: (2019)

Engineered model of t(7;12)(q36;p13) AML recapitulates patient-specific features and gene expression profiles
por: Ragusa, Denise, et al.
Publicado: (2022)

Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker
por: Yang, Yaqi, et al.
Publicado: (2022)

A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker
por: HUANG, YANGQING, et al.
Publicado: (2023)

Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
por: Fäldt Beding, Anna, et al.
Publicado: (2022)

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022)

Spectrum of MNX1 Pathogenic Variants and Associated Clinical Features in Korean Patients with Currarino Syndrome
por: Lee, Seungjun, et al.
Publicado: (2018)

The pan-cancer analysis identified DIAPH3 as a diagnostic biomarker of clinical cancer
por: Chen, Xiaowei, et al.
Publicado: (2023)

Retraction statement: Knockdown of lncRNA MNX1‐AS1 suppresses cell proliferation, migration, and invasion in prostate cancer
Publicado: (2022)

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
por: Cheng, Xin, et al.
Publicado: (2021)

Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker
por: Zhang, Rui, et al.
Publicado: (2022)

Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma
por: Xu, Lei, et al.
Publicado: (2022)

Systematic pan-cancer analysis identifies cGAS as an immunological and prognostic biomarker
por: Chen, Peng, et al.
Publicado: (2023)

Analysis of Transcription Factors Key for Mouse Pancreatic Development Establishes NKX2-2 and MNX1 Mutations as Causes of Neonatal Diabetes in Man
por: Flanagan, Sarah E., et al.
Publicado: (2014)

Pan cancer characterization of genes whose expression has been associated with LINE-1 antisense promoter activity
por: Xu, Baohong, et al.
Publicado: (2023)

MNX1 reduces sensitivity to anoikis by activating TrkB in human glioma cells
por: Jiang, Lai, et al.
Publicado: (2018)

Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes
por: Luo, Zhenhua, et al.
Publicado: (2019)

Biogenic manganese oxide nanoparticle formation by a multimeric multicopper oxidase Mnx
por: Romano, Christine A., et al.
Publicado: (2017)

Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer
por: Yu, Yang, et al.
Publicado: (2023)

Pan-cancer proteogenomic investigations identify post-transcriptional kinase targets
por: Elmas, Abdulkadir, et al.
Publicado: (2021)

Systematic pan-cancer analysis identifies SLC35C1 as an immunological and prognostic biomarker
por: Xie, Mingchen, et al.
Publicado: (2023)

Machine Learning-Based Comparative Analysis of Pan-Cancer and Pan-Normal Tissues Identifies Pan-Cancer Tissue-Enriched circRNAs Related to Cancer Mutations as Potential Exosomal Biomarkers
por: Wang, Xuezhu, et al.
Publicado: (2021)

PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
por: Ali, Mohamad Moustafa, et al.
Publicado: (2018)

Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
por: Xu, Yingting, et al.
Publicado: (2023)

Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy
por: Li, Ya-Dong, et al.
Publicado: (2023)

Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer
por: Zhou, Libo, et al.
Publicado: (2023)

Pan‑cancer analysis identified ARHGAP23 as a potential biomarker for pancreatic adenocarcinoma
por: Liu, Xiaolong, et al.
Publicado: (2023)

Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers
por: Schwartz, Gregory W., et al.
Publicado: (2018)

Mechanisms associated with t(7;12) acute myeloid leukaemia: from genetics to potential treatment targets
por: Ragusa, Denise, et al.
Publicado: (2023)

Pan-Cancer Analysis Reveals the Prognostic Potential of the THAP9/THAP9-AS1 Sense–Antisense Gene Pair in Human Cancers
por: Rashmi, Richa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ok43p4ha43e5b7v2qfi8j1k92t